HUT75069A - A nucleic acid diagnostic method using riboprobes, rnase digestion, and molecular weight exclusion chromatography - Google Patents

A nucleic acid diagnostic method using riboprobes, rnase digestion, and molecular weight exclusion chromatography Download PDF

Info

Publication number: HUT75069A
Authority: HU; Hungary
Prior art keywords: nucleic acid; probe; dna; target; hybridization
Prior art date: 1993-10-22

Application number

HU9602069A

Other languages

English (en)

Hungarian (hu)

Other versions

HU9602069D0 (en

Inventor

Calvert L Green

Frederick W Jacobsen

Francis H Martin

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-22

Filing date

1994-10-19

Publication date

1997-04-28

1994-10-19 Application filed by Amgen Inc filed Critical Amgen Inc

1996-09-30 Publication of HU9602069D0 publication Critical patent/HU9602069D0/hu

1997-04-28 Publication of HUT75069A publication Critical patent/HUT75069A/hu

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 112
102000039446 nucleic acids Human genes 0.000 title claims abstract description 93
108020004707 nucleic acids Proteins 0.000 title claims abstract description 93
238000002270 exclusion chromatography Methods 0.000 title claims description 10
230000029087 digestion Effects 0.000 title abstract description 16
238000002405 diagnostic procedure Methods 0.000 title abstract description 13
238000000034 method Methods 0.000 claims abstract description 154
239000000523 sample Substances 0.000 claims abstract description 127
238000009396 hybridization Methods 0.000 claims abstract description 91
108020004414 DNA Proteins 0.000 claims description 110
108020004518 RNA Probes Proteins 0.000 claims description 32
239000003391 RNA probe Substances 0.000 claims description 32
108091028043 Nucleic acid sequence Proteins 0.000 claims description 24
108010083644 Ribonucleases Proteins 0.000 claims description 24
102000006382 Ribonucleases Human genes 0.000 claims description 24
230000008569 process Effects 0.000 claims description 12
241000700605 Viruses Species 0.000 claims description 11
239000007788 liquid Substances 0.000 claims description 11
206010028980 Neoplasm Diseases 0.000 claims description 10
239000003792 electrolyte Substances 0.000 claims description 10
102000053602 DNA Human genes 0.000 claims description 9
244000052769 pathogen Species 0.000 claims description 9
241000894006 Bacteria Species 0.000 claims description 8
208000026350 Inborn Genetic disease Diseases 0.000 claims description 8
239000012472 biological sample Substances 0.000 claims description 8
230000002068 genetic effect Effects 0.000 claims description 8
239000003550 marker Substances 0.000 claims description 8
230000001717 pathogenic effect Effects 0.000 claims description 7
230000001580 bacterial effect Effects 0.000 claims description 6
208000016361 genetic disease Diseases 0.000 claims description 6
208000035269 cancer or benign tumor Diseases 0.000 claims description 5
230000003612 virological effect Effects 0.000 claims description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
241000233866 Fungi Species 0.000 claims description 4
230000027455 binding Effects 0.000 claims description 4
238000002844 melting Methods 0.000 claims description 3
230000008018 melting Effects 0.000 claims description 3
244000052616 bacterial pathogen Species 0.000 claims description 2
229960002685 biotin Drugs 0.000 claims description 2
235000020958 biotin Nutrition 0.000 claims description 2
239000011616 biotin Substances 0.000 claims description 2
238000011161 development Methods 0.000 claims description 2
230000003211 malignant effect Effects 0.000 claims description 2
239000000700 radioactive tracer Substances 0.000 claims description 2
230000009870 specific binding Effects 0.000 claims description 2
108090001008 Avidin Proteins 0.000 claims 1
238000004374 forensic analysis Methods 0.000 claims 1
244000053095 fungal pathogen Species 0.000 claims 1
244000052613 viral pathogen Species 0.000 claims 1
238000001514 detection method Methods 0.000 abstract description 26
230000000295 complement effect Effects 0.000 abstract description 18
238000007899 nucleic acid hybridization Methods 0.000 abstract description 16
238000011160 research Methods 0.000 abstract description 4
238000013375 chromatographic separation Methods 0.000 abstract 1
241000701806 Human papillomavirus Species 0.000 description 86
239000000243 solution Substances 0.000 description 53
210000004027 cell Anatomy 0.000 description 47
108091032973 (ribonucleotides)n+m Proteins 0.000 description 37
125000003729 nucleotide group Chemical group 0.000 description 33
239000000203 mixture Substances 0.000 description 31
239000002773 nucleotide Substances 0.000 description 31
108020004999 messenger RNA Proteins 0.000 description 29
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 27
238000003556 assay Methods 0.000 description 26
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
230000014509 gene expression Effects 0.000 description 24
108090000623 proteins and genes Proteins 0.000 description 24
239000000872 buffer Substances 0.000 description 23
239000012634 fragment Substances 0.000 description 23
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
238000006243 chemical reaction Methods 0.000 description 20
239000011541 reaction mixture Substances 0.000 description 20
201000008752 progressive muscular atrophy Diseases 0.000 description 17
239000013598 vector Substances 0.000 description 16
238000013518 transcription Methods 0.000 description 15
230000035897 transcription Effects 0.000 description 15
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 14
239000011780 sodium chloride Substances 0.000 description 14
238000012360 testing method Methods 0.000 description 14
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 12
239000011159 matrix material Substances 0.000 description 12
238000004458 analytical method Methods 0.000 description 11
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 11
239000000835 fiber Substances 0.000 description 11
235000019333 sodium laurylsulphate Nutrition 0.000 description 11
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 10
241000701828 Human papillomavirus type 11 Species 0.000 description 10
208000009608 Papillomavirus Infections Diseases 0.000 description 10
230000015572 biosynthetic process Effects 0.000 description 10
230000000694 effects Effects 0.000 description 10
238000010348 incorporation Methods 0.000 description 10
210000003593 megakaryocyte Anatomy 0.000 description 10
238000003786 synthesis reaction Methods 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
238000004448 titration Methods 0.000 description 9
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 8
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 8
238000000376 autoradiography Methods 0.000 description 8
201000010099 disease Diseases 0.000 description 8
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
230000006698 induction Effects 0.000 description 8
239000013612 plasmid Substances 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
108090000778 Platelet factor 4 Proteins 0.000 description 7
108091028664 Ribonucleotide Proteins 0.000 description 7
208000015181 infectious disease Diseases 0.000 description 7
238000000746 purification Methods 0.000 description 7
239000002336 ribonucleotide Substances 0.000 description 7
125000002652 ribonucleotide group Chemical group 0.000 description 7
230000035945 sensitivity Effects 0.000 description 7
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
229920002684 Sepharose Polymers 0.000 description 6
101710137500 T7 RNA polymerase Proteins 0.000 description 6
238000004587 chromatography analysis Methods 0.000 description 6
YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 6
238000003745 diagnosis Methods 0.000 description 6
230000035800 maturation Effects 0.000 description 6
239000002245 particle Substances 0.000 description 6
239000011734 sodium Substances 0.000 description 6
ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 6
239000006228 supernatant Substances 0.000 description 6
229920000936 Agarose Polymers 0.000 description 5
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
239000000020 Nitrocellulose Substances 0.000 description 5
108020004711 Nucleic Acid Probes Proteins 0.000 description 5
108091034117 Oligonucleotide Proteins 0.000 description 5
102000004211 Platelet factor 4 Human genes 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
229920001220 nitrocellulos Polymers 0.000 description 5
239000002853 nucleic acid probe Substances 0.000 description 5
239000008188 pellet Substances 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
238000011002 quantification Methods 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
238000012216 screening Methods 0.000 description 5
239000011550 stock solution Substances 0.000 description 5
108010067770 Endopeptidase K Proteins 0.000 description 4
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 4
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 4
238000002105 Southern blotting Methods 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
238000000246 agarose gel electrophoresis Methods 0.000 description 4
239000000427 antigen Substances 0.000 description 4
102000036639 antigens Human genes 0.000 description 4
108091007433 antigens Proteins 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
238000010367 cloning Methods 0.000 description 4
238000004440 column chromatography Methods 0.000 description 4
230000009089 cytolysis Effects 0.000 description 4
238000001914 filtration Methods 0.000 description 4
239000003102 growth factor Substances 0.000 description 4
238000007901 in situ hybridization Methods 0.000 description 4
230000002458 infectious effect Effects 0.000 description 4
239000012139 lysis buffer Substances 0.000 description 4
239000002609 medium Substances 0.000 description 4
238000004806 packaging method and process Methods 0.000 description 4
239000013600 plasmid vector Substances 0.000 description 4
108091008146 restriction endonucleases Proteins 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
JCLFHZLOKITRCE-UHFFFAOYSA-N 4-pentoxyphenol Chemical compound CCCCCOC1=CC=C(O)C=C1 JCLFHZLOKITRCE-UHFFFAOYSA-N 0.000 description 3
206010059313 Anogenital warts Diseases 0.000 description 3
208000000907 Condylomata Acuminata Diseases 0.000 description 3
239000003298 DNA probe Substances 0.000 description 3
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 3
102000005891 Pancreatic ribonuclease Human genes 0.000 description 3
239000002253 acid Substances 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
238000013019 agitation Methods 0.000 description 3
208000025009 anogenital human papillomavirus infection Diseases 0.000 description 3
201000004201 anogenital venereal wart Diseases 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
238000010828 elution Methods 0.000 description 3
230000007717 exclusion Effects 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
239000000499 gel Substances 0.000 description 3
210000000777 hematopoietic system Anatomy 0.000 description 3
238000002955 isolation Methods 0.000 description 3
239000006166 lysate Substances 0.000 description 3
229910001629 magnesium chloride Inorganic materials 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
238000005259 measurement Methods 0.000 description 3
239000012528 membrane Substances 0.000 description 3
239000011347 resin Substances 0.000 description 3
229920005989 resin Polymers 0.000 description 3
238000003345 scintillation counting Methods 0.000 description 3
238000000926 separation method Methods 0.000 description 3
229940063673 spermidine Drugs 0.000 description 3
238000010186 staining Methods 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
239000000758 substrate Substances 0.000 description 3
238000004809 thin layer chromatography Methods 0.000 description 3
238000001890 transfection Methods 0.000 description 3
230000009466 transformation Effects 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
108091033380 Coding strand Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
102000016911 Deoxyribonucleases Human genes 0.000 description 2
108010053770 Deoxyribonucleases Proteins 0.000 description 2
201000010374 Down Syndrome Diseases 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
241000341655 Human papillomavirus type 16 Species 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
239000006142 Luria-Bertani Agar Substances 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
208000024556 Mendelian disease Diseases 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
108020005187 Oligonucleotide Probes Proteins 0.000 description 2
241001631646 Papillomaviridae Species 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
102100030304 Platelet factor 4 Human genes 0.000 description 2
108091034057 RNA (poly(A)) Proteins 0.000 description 2
230000006819 RNA synthesis Effects 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
108091027544 Subgenomic mRNA Proteins 0.000 description 2
208000026062 Tissue disease Diseases 0.000 description 2
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
230000004075 alteration Effects 0.000 description 2
238000000137 annealing Methods 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
238000001976 enzyme digestion Methods 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
108010079502 exoribonuclease T Proteins 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
-1 free nucleotides Chemical class 0.000 description 2
230000006870 function Effects 0.000 description 2
210000004392 genitalia Anatomy 0.000 description 2
239000011521 glass Substances 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
230000012010 growth Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000012678 infectious agent Substances 0.000 description 2
230000003902 lesion Effects 0.000 description 2
238000005567 liquid scintillation counting Methods 0.000 description 2
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
230000004807 localization Effects 0.000 description 2
238000013507 mapping Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
239000002751 oligonucleotide probe Substances 0.000 description 2
230000008520 organization Effects 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
239000012071 phase Substances 0.000 description 2
230000003169 placental effect Effects 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
239000000047 product Substances 0.000 description 2
239000003380 propellant Substances 0.000 description 2
238000001243 protein synthesis Methods 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
239000000376 reactant Substances 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
108010068698 spleen exonuclease Proteins 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000010998 test method Methods 0.000 description 2
230000014616 translation Effects 0.000 description 2
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
238000003260 vortexing Methods 0.000 description 2
238000005406 washing Methods 0.000 description 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
238000012935 Averaging Methods 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
206010008342 Cervix carcinoma Diseases 0.000 description 1
235000007836 Chlorogalum pomeridianum Nutrition 0.000 description 1
240000006670 Chlorogalum pomeridianum Species 0.000 description 1
208000011359 Chromosome disease Diseases 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
108020004394 Complementary RNA Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
238000009007 Diagnostic Kit Methods 0.000 description 1
208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
208000036566 Erythroleukaemia Diseases 0.000 description 1
102000003951 Erythropoietin Human genes 0.000 description 1
108090000394 Erythropoietin Proteins 0.000 description 1
241001452028 Escherichia coli DH1 Species 0.000 description 1
241000702192 Escherichia virus P2 Species 0.000 description 1
YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
206010061978 Genital lesion Diseases 0.000 description 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
101001042147 Hordeum vulgare Subtilisin-chymotrypsin inhibitor-2B Proteins 0.000 description 1
102000000646 Interleukin-3 Human genes 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
102000004889 Interleukin-6 Human genes 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
208000002471 Penile Neoplasms Diseases 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004365 Protease Substances 0.000 description 1
241000219492 Quercus Species 0.000 description 1
108010065868 RNA polymerase SP6 Proteins 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
108010046983 Ribonuclease T1 Proteins 0.000 description 1
101710141795 Ribonuclease inhibitor Proteins 0.000 description 1
229940122208 Ribonuclease inhibitor Drugs 0.000 description 1
102100037968 Ribonuclease inhibitor Human genes 0.000 description 1
241001468001 Salmonella virus SP6 Species 0.000 description 1
239000012506 Sephacryl® Substances 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
208000019802 Sexually transmitted disease Diseases 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
208000005485 Thrombocytosis Diseases 0.000 description 1
206010044688 Trisomy 21 Diseases 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
208000004354 Vulvar Neoplasms Diseases 0.000 description 1
208000000260 Warts Diseases 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
208000021841 acute erythroid leukemia Diseases 0.000 description 1
239000008272 agar Substances 0.000 description 1
VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
239000009895 amole Substances 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000003321 amplification Effects 0.000 description 1
244000037640 animal pathogen Species 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
210000003651 basophil Anatomy 0.000 description 1
230000008901 benefit Effects 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
108091092356 cellular DNA Proteins 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
241000902900 cellular organisms Species 0.000 description 1
201000010881 cervical cancer Diseases 0.000 description 1
230000003196 chaotropic effect Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000012504 chromatography matrix Substances 0.000 description 1
208000024971 chromosomal disease Diseases 0.000 description 1
229940047120 colony stimulating factors Drugs 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
229960002086 dextran Drugs 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000003480 eluent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
229940125532 enzyme inhibitor Drugs 0.000 description 1
229940105423 erythropoietin Drugs 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000008187 granular material Substances 0.000 description 1
238000000227 grinding Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
244000052637 human pathogen Species 0.000 description 1
230000028993 immune response Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229940076264 interleukin-3 Drugs 0.000 description 1
229940100601 interleukin-6 Drugs 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
238000007826 nucleic acid assay Methods 0.000 description 1
238000012856 packing Methods 0.000 description 1
150000004633 phorbol derivatives Chemical class 0.000 description 1
239000002644 phorbol ester Substances 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
244000000003 plant pathogen Species 0.000 description 1
230000007505 plaque formation Effects 0.000 description 1
238000007747 plating Methods 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000003793 prenatal diagnosis Methods 0.000 description 1
238000004801 process automation Methods 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
239000012521 purified sample Substances 0.000 description 1
238000012797 qualification Methods 0.000 description 1
238000012207 quantitative assay Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
230000014493 regulation of gene expression Effects 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
238000004153 renaturation Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
238000007789 sealing Methods 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000002002 slurry Substances 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000012956 testing procedure Methods 0.000 description 1
206010043554 thrombocytopenia Diseases 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

HU9602069A 1993-10-22 1994-10-19 A nucleic acid diagnostic method using riboprobes, rnase digestion, and molecular weight exclusion chromatography HUT75069A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US14171193A	1993-10-22	1993-10-22

Publications (2)

Publication Number	Publication Date
HU9602069D0 HU9602069D0 (en)	1996-09-30
HUT75069A true HUT75069A (en)	1997-04-28

Family

ID=22496882

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9602069A HUT75069A (en)	1993-10-22	1994-10-19	A nucleic acid diagnostic method using riboprobes, rnase digestion, and molecular weight exclusion chromatography

Country Status (6)

Country	Link
EP (1)	EP0738331A1 (fr)
AU (1)	AU8085394A (fr)
CA (1)	CA2182194A1 (fr)
HU (1)	HUT75069A (fr)
NZ (1)	NZ275286A (fr)
WO (1)	WO1995011316A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2737502B1 (fr) *	1995-07-31	1997-10-24	Genset Sa	Procede de detection d'acides nucleiques utilisant des sondes nucleotidiques permettant a la fois une capture specifique et une detection
US20060234277A1 (en) *	2005-03-31	2006-10-19	Amgen Inc.	Method for selectively blocking hemoglobin RNA amplification
EP2478088B1 (fr) *	2009-09-16	2016-08-31	Life Technologies Corporation	Tampons de lyse pour extraire des acides nucléiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0229442B1 (fr) *	1986-01-07	1993-01-27	Gen-Probe Incorporated	Procédé de réassociation accélérée d'acide nucléique
WO1992018649A1 (fr) *	1991-04-12	1992-10-29	Microprobe Corporation	Compositions et procedes d'extraction et d'hybridation ameliorees d'acide nucleique

1994
- 1994-10-19 WO PCT/US1994/012044 patent/WO1995011316A1/fr not_active Ceased
- 1994-10-19 HU HU9602069A patent/HUT75069A/hu unknown
- 1994-10-19 EP EP94931951A patent/EP0738331A1/fr not_active Withdrawn
- 1994-10-19 CA CA002182194A patent/CA2182194A1/fr not_active Abandoned
- 1994-10-19 NZ NZ275286A patent/NZ275286A/en unknown
- 1994-10-19 AU AU80853/94A patent/AU8085394A/en not_active Abandoned

Also Published As

Publication number	Publication date
HU9602069D0 (en)	1996-09-30
NZ275286A (en)	1998-08-26
WO1995011316A1 (fr)	1995-04-27
EP0738331A1 (fr)	1996-10-23
CA2182194A1 (fr)	1995-04-27
AU8085394A (en)	1995-05-08

Legal Events

Date	Code	Title	Description
1999-12-28	DFC4	Cancellation of temporary prot. due to refusal

Publication	Publication Date	Title
KR100245283B1 (ko)	2000-03-02	인 시튜 혼성화 방법(in situ hybridization method)
US20090203072A1 (en)	2009-08-13	Detection for HPV-Induced invasive cancers and their precursor lesions with invasive potential
CA2262403A1 (fr)	1998-02-05	Biomarqueurs et cibles de diagnostic, de pronostic et de traitement du cancer de la prostate
CN113684317B (zh)	2023-09-26	一种基于CRISPR-Cas12b对乙肝病毒B型和C型的超灵敏快速检测及鉴别系统
JP2003535600A (ja)	2003-12-02	インサイチュ分枝ｄｎａハイブリダイゼーションを用いた高感度遺伝子検出および位置決定
HUE019019T5 (en)	2017-04-28	Methods for Using miRNA for In vivo Cell Death Detection
JPH02501442A (ja)	1990-05-24	ヌクレオチドプローブによるヒト乳頭腫の型の診断
US10161005B2 (en)	2018-12-25	Method for detecting telomerase via washing-free anchored-extension and telomeric-binding amplification, and kit
EP1220954B1 (fr)	2005-04-20	Amorces et sondes d'acides nucleiques permettant de detecter des cellules tumorales
CN113316648A (zh)	2021-08-27	病毒性hpv或hiv基因组的整合与hpv相关宫颈病变或艾滋病病理学疾病的严重程度和/或临床结果之间的关联
Van Gijlswijk et al.	1996	Horseradish peroxidase-labeled oligonucleotides and fluorescent tyramides for rapid detection of chromosome-specific repeat sequences
JP2000500018A (ja)	2000-01-11	真核系サンプル中の特異的核酸配列を検出するためのｉｎｓｉｔｕハイブリダイゼーション
Heino et al.	1989	Detection of human papilloma virus (HPV) DNA in genital biopsy specimens by in situ hybridization with digoxigenin-labeled probes
US6180344B1 (en)	2001-01-30	5′ Upstream region sequences of the MyoD1 gene and uses thereof
Jaye et al.	2003	Use of real-time polymerase chain reaction to identify cell-and tissue-type-selective peptides by phage display
US20130171622A1 (en)	2013-07-04	Compositions and methods for detecting viral infection using direct-label fluorescence in situ hybridization
CN113930501A (zh)	2022-01-14	人egfr基因突变的数字pcr检测方法及应用
EP1212460B1 (fr)	2008-02-13	Procede et reactifs d'amplification in situ
JP5476989B2 (ja)	2014-04-23	ゲノムｄｎａ断片の増幅または欠失の検出方法
Rose et al.	1995	Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction
EP0738331A1 (fr)	1996-10-23	METHODE DIAGNOSTIQUE DE L'ACIDE NUCLEIQUE RECOURANT AUX RIBOSONDES, A LA DIGESTION DE LA RNAse ET A LA CHROMATOGRAPHIE PAR EXCLUSION DE POIDS MOLECULAIRE
JP2001504703A (ja)	2001-04-10	頸部病変の進行ポテンシャルを評価するためのｄｎａ
JPH07502893A (ja)	1995-03-30	核酸ハイブリッド形成アッセイにおける、またはそれに関する改良
JPH0653080B2 (ja)	1994-07-20	生物材料中の核酸を生体外検出するための方法及びキット
JPH07250700A (ja)	1995-10-03	競合ｐｃｒ法による核酸の簡易定量法